Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01606852Phase 2Completed
A Phase 2 trial of dexmedetomidine in anxiety disorder, sponsored by University of Minnesota. Started Mar 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01606852.